Latest Insider Transactions at Cue Biopharma, Inc. (CUE)
This section provides a real-time view of insider transactions for Cue Biopharma, Inc. (CUE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cue Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cue Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Cameron Gray Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.74%
|
$75,000
$15.0 P/Share
|